These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 29807360
1. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy. Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, Li H, Chen H. Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360 [Abstract] [Full Text] [Related]
2. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer. Liu F, Liu B, Qian J, Wu G, Li J, Ma Z. Acta Biochim Biophys Sin (Shanghai); 2017 Jun 01; 49(6):520-529. PubMed ID: 28459992 [Abstract] [Full Text] [Related]
3. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer. Zhang X, Zhao P, Wang C, Xin B. Biochem Biophys Res Commun; 2019 Mar 19; 510(4):508-514. PubMed ID: 30737032 [Abstract] [Full Text] [Related]
4. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis. Liu X, Luo X, Wu Y, Xia D, Chen W, Fang Z, Deng J, Hao Y, Yang X, Zhang T, Zhou L, Wu Y, Wang Q, Xu J, Hu X, Li L. Cell Physiol Biochem; 2018 Mar 19; 50(1):261-276. PubMed ID: 30282072 [Abstract] [Full Text] [Related]
5. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer. Liu YF, Luo D, Li X, Li ZQ, Yu X, Zhu HW. Pancreas; 2021 Feb 01; 50(2):227-234. PubMed ID: 33565800 [Abstract] [Full Text] [Related]
6. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells. Hu W, Liu Q, Pan J, Sui Z. Biomed Pharmacother; 2018 Sep 01; 105():887-898. PubMed ID: 30021382 [Abstract] [Full Text] [Related]
7. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway. Jiang S, Song C, Gu X, Wang M, Miao D, Lv J, Liu Y. Cell Physiol Biochem; 2018 Sep 01; 46(4):1412-1422. PubMed ID: 29689565 [Abstract] [Full Text] [Related]
12. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ, Zhang Q, Wang R, Zhang HZ. Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1055-64. PubMed ID: 18297287 [Abstract] [Full Text] [Related]
13. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway. Ma H, Kong L, Liu L, Du Y, Zhu X, Wang J, Zhao W. Mol Carcinog; 2024 Jul 01; 63(7):1221-1234. PubMed ID: 38517039 [Abstract] [Full Text] [Related]
14. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2. Xiao G, Wang X, Yu Y. Cell Physiol Biochem; 2017 Jul 01; 43(2):840-851. PubMed ID: 28954272 [Abstract] [Full Text] [Related]
15. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis. Liu X, Liu X, Wu Y, Fang Z, Wu Q, Wu C, Hao Y, Yang X, Zhao J, Li J, Wang Q, Yang Z, Xu J, Hu X, Tan M, Li L. Cell Physiol Biochem; 2018 Jul 01; 48(1):87-98. PubMed ID: 30001529 [Abstract] [Full Text] [Related]
16. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer. Yu S, Wang M, Zhang H, Guo X, Qin R. J Cell Mol Med; 2024 Jun 01; 28(12):e18444. PubMed ID: 38924205 [Abstract] [Full Text] [Related]
17. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Ma C, Huang T, Ding YC, Yu W, Wang Q, Meng B, Luo SX. Int J Clin Exp Pathol; 2015 Jun 01; 8(6):6533-9. PubMed ID: 26261532 [Abstract] [Full Text] [Related]
18. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J, Xu Y, Tao L, Pan Y, Zhang K, Wang R, Chen LB, Chu X. Cell Physiol Biochem; 2017 Jun 01; 41(2):583-597. PubMed ID: 28214878 [Abstract] [Full Text] [Related]
19. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway. Wu Y, Xu W, Yang Y, Zhang Z. Ann Clin Lab Sci; 2021 May 01; 51(3):310-320. PubMed ID: 34162560 [Abstract] [Full Text] [Related]
20. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali DW, Michalak M, Chen XZ, Tang J. Mol Cancer; 2020 Jul 29; 19(1):118. PubMed ID: 32727463 [Abstract] [Full Text] [Related] Page: [Next] [New Search]